Results 211 to 220 of about 13,261 (250)

Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report. [PDF]

open access: yesPan Afr Med J
Smaoui E   +7 more
europepmc   +1 more source

Chronic inflammatory demyelinating polyneuropathy [PDF]

open access: possibleCurrent Treatment Options in Neurology, 1999
Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) requires long-term immunomodulatory therapy, which has potential side effects. Before such therapy is instituted, a firm diagnosis of CIDP must be established. Prednisone, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are all proven first-line therapies for CIDP that ...
David S. Saperstein, Jonathan S. Katz
openaire   +3 more sources

Immunoglobulins in chronic inflammatory demyelinating polyneuropathy [PDF]

open access: possibleNeurological Sciences, 2003
This article reviews the efficacy and tolerability of intravenous immunoglobulins (IVIg) in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), including those forms associated with monoclonal gammopathy (paraproteinemic demyelinating neuropathy, PDN). Class I trials demonstrated that IVIg are effective in CIDP.
COMI , GIANCARLO   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy